30
Participants
Start Date
August 24, 2004
Primary Completion Date
December 6, 2013
Study Completion Date
December 6, 2013
Pasireotide
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Edegem
Novartis Investigative Site, Woolloongabba
NYU / VA Medical Center, New York
Novartis Investigative Site, Toulouse Cédex 4
Novartis Investigative Site, Essen
University of Michigan Health System StudyCoordinatorCSOM230B2201E1, Ann Arbor
Novartis Investigative Site, Napoli
Novartis Investigative Site, München
Cedars Sinai Medical Center Dept. of Pituitary Ctr., Los Angeles
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY